outcomes and psoriatic arthritis Archives

Abstract Number: 2138 • ACR/ARHP Annual Meeting 2018
Real-World Evaluation of Treatment Patterns of Methotrexate Users in Psoriatic Arthritis
Brian Ung¹, Dionne Hines², Sandhya Mehta¹, Corey Pelletier¹, Xin Wang² and Rolin Wade², ¹Celgene Corporation, Summit, NJ, ²IQVIA, Durham, NC
Background/Purpose: Methotrexate (MTX) is commonly used to treat psoriatic arthritis (PsA), yet data supporting its effectiveness in PsA are limited. This analysis describes real-world dosing,…
Abstract Number: 694 • ACR/ARHP Annual Meeting 2016
Diagnostic Delay Leads to Worse Response to Treatment
Marijn Vis¹, Kim Wervers², Ilja Tchetverikov³, Mark R. Kok⁴, Lindy-Anne Korswagen⁵, Andreas H. Gerards⁶, Hans van Groenendaal⁷, Jozien Veris⁸, Wiebo L. van der Graaff⁹, Cathelijne W. Y. Appels¹⁰, Johanna M.W. Hazes¹¹ and Jolanda J. Luime¹, ¹Rheumatology, Erasmus Medical Centre, Rotterdam, Netherlands, ²Erasmus Medical Centre, Rotterdam, Netherlands, ³Albert Schweitzer Hospital, Dordrecht, Netherlands, ⁴Rheumatology, Maasstad Hospital, Rotterdam, Netherlands, ⁵Sint Franciscus Gasthuis, Rotterdam, Netherlands, ⁶Rheumatology, Vlietland Hospital, Schiedam, Netherlands, ⁷Rheumatology, ReumaZorg ZuidWest nederland, Roosendaal, Netherlands, ⁸Rheumatology, Reumazorg Zuid West Nederland, Goes, Netherlands, ⁹Rheumatology, Rivas hospital, Gorinchem, Netherlands, ¹⁰Rheumatology, Amphia Hospital, Breda, Netherlands, ¹¹Department of Rheumatology, Erasmus University Medical Centre, Rotterdam, Netherlands
Is there a clinical patient profile for PsA Patients with a diagnostic delay? Background/Purpose: Psoriatic arthritis (PsA) is a progressive inflammatory musculoskeletal disease. Several recent…

Abstracts tagged "outcomes and psoriatic arthritis"

Real-World Evaluation of Treatment Patterns of Methotrexate Users in Psoriatic Arthritis

Diagnostic Delay Leads to Worse Response to Treatment